Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

2.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rheumatoid Arthritis in the Cervical Spine: An Updated Review of Epidemiology, Imaging, and Surgical Indications.

Spine surgery and related research·2026
Same author

Complications Following Cervical Laminoplasty With Reconstruction: A Systematic Review and Meta-Analysis.

Spine·2026
Same author

Intradiscal <i>Cutibacterium acnes</i> Sustains Modic Type 1-Like Lesions Over Time in a Rat Lumbar Endplate Injury Model.

JOR spine·2026
Same author

A Decade of Leadership and Impact: Celebrating 10 Years of the ORS Spine Section.

JOR spine·2026
Same author

Increasing Incidence of Cervical Spine Injuries in the United States: An Age- and Sex-specific Analysis of National Injury Data.

Clinical spine surgery·2026
Same author

Raloxifene injections normalize age-related mechanical sensitization in female and male mice and augment intervertebral disc structure in old female mice.

Osteoarthritis and cartilage·2026

Related Experiment Video

Updated: Apr 5, 2026

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
10:23

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach

Published on: August 26, 2013

14.6K

Association Between BMP-2 and Carcinogenicity.

Branko Skovrlj1, Steven M Koehler, Paul A Anderson

  • 1*Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY †Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY ‡Department of Orthopaedics and Rehabilitation, University of Wisconsin, Madison, WI.

Spine
|August 15, 2015
PubMed
Summary
This summary is machine-generated.

Recombinant human bone morphogenetic protein-2 (rhBMP-2) has conflicting associations with malignancy, with some studies showing enhancement and others suppression. No studies demonstrated rhBMP-2 causing cancer de novo, but more research is needed.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

15.7K
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

8.2K

Related Experiment Videos

Last Updated: Apr 5, 2026

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach
10:23

Covalent Binding of BMP-2 on Surfaces Using a Self-assembled Monolayer Approach

Published on: August 26, 2013

14.6K
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

Published on: December 19, 2019

15.7K
Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

8.2K

Area of Science:

  • Biomedical research
  • Oncology
  • Regenerative medicine

Background:

  • The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in spinal fusion surgery is debated due to conflicting findings on its association with malignancy.
  • Existing literature presents inconsistent conclusions regarding the link between rhBMP-2 and cancer development or progression.

Purpose of the Study:

  • To systematically review and evaluate the association between rhBMP-2 and malignancy.
  • To synthesize findings from non-clinical studies investigating the role of BMP-2 in cancer.

Main Methods:

  • A systematic literature review was conducted using PubMed.
  • Included studies were non-clinical, focusing on BMP-2 and cancer.
  • Articles were categorized by study type (in vitro, animal), cancer type, and BMP-2's effect (enhancement, suppression, or neutral).

Main Results:

  • Out of 4,131 reviewed articles, 99 directly examined the role of BMP-2 in cancer.
  • 43% of studies suggested BMP-2 enhances tumor function, while 18% found it suppressed malignancy.
  • No study demonstrated that BMP-2 caused cancer de novo, but dose and time dependence were observed in some studies.

Conclusions:

  • Conflicting data persist regarding the effect of exogenous BMP-2 on cancer.
  • The majority of research focused on prostate, breast, and lung cancers, primarily using in vitro models.
  • While BMP-2 did not cause cancer de novo, its potential to enhance tumor function warrants further investigation, including clinically relevant dose- and time-dependence studies.